MilliporeSigma
Search Within
Document Type

278-169-7

Applied Filters:
Keyword:'278-169-7'
Showing 1-30 of 37 results for "278-169-7" within Technical Documents
Anisomycin from Streptomyces griseolus (A9789)
Commun., 278, 550-6 (2000) 5. Curtin. J.F. and Cotter T.G., Br. J. Cancer, 87, 1188-94 (2002). 6. Torocsik, B. and Szeberenyi. J., Eur. J. Neurosci., 12, 527-32 (2000).
Data Sheet - G6916
, and Lane M.D., Proc. Natl. Acad. Sci. USA , 97, 12446-12450 (2000). 7. O’Reilly, M.A., et al., Am. J. Physiol., 278, L552-L559 (2000). 8. Cui, K., et al., J. Biol. Chem., 275
Data Sheet - P0050
Manevich, Y., and Fisher, A.B., Free Radic. Biol. Med., 38, 1422-1432 (2005). 7. Kumin, A. et al., Am. J. Pathol., 169, 1194-1205 (2006). 8. Power, J.H.T. et al., Acta Neuropathol., 115, 611-
Data Sheet - P0058
Manevich, Y., and Fisher, A.B., Free Radic. Biol. Med., 38, 1422-1432 (2005). 7. Kumin, A. et al., Am. J. Pathol., 169, 1194-1205 (2006). 8. Power, J.H.T. et al., Acta Neuropathol., 115, 611-
Product Information Sheet - P0453
phosphotyrosyl phosphatase inhibitors leads to activation of cyclooxygenase-2 gene. J. Biol. Chem., 278(9), 6992-7000 (2003). 6. Cambien, B., et al., Src-regulated extracellular signal-related kinase
Data Sheet - M6569
, M., et al., Gene, 301, 43-51 (2002). 7. Razin, A., and Cedar, H., Cell, 77, 473-476 (1994). 8. Riggs, A.D., and Pfeifer, G.P., Trends Genet., 8, 169-174 (1992). 9. Sakai, T., et al., Am.
Data Sheet - T2200
1799 (1990). 5. MacRae, T.H., Eur. J. Biochem., 244, 265-278 (1997). 6. Roach, M.C., et al., Cell Motil. Cytoskel., 39, 273-285 (1998). 7. Luduena, R.F., Int. Rev. Cytol., 178, 207-275 (1998
MRS 1845- A blocker of store-operated calcium (SOC) entry that does not activate intracellular calcium release
(1999). 2. Barritt, G.J., Biochem. J., 337, 153-169 (1999). 3. Nilius, B., et al., Endothelium, 10, 5-15 (2003). 4. Liu, X., et al., J. Biol. Chem., 278, 11337-11343 (2003). 5. Harper, J.L., et al., Biochem
A blocker of store-operated calcium (SOC) entry (MRS1845)
(1999). 2. Barritt, G.J., Biochem. J., 337, 153-169 (1999). 3. Nilius, B., et al., Endothelium, 10, 5-15 (2003). 4. Liu, X., et al., J. Biol. Chem., 278, 11337-11343 (2003). 5. Harper, J.L., et al., Biochem
HEPES Sodium Salt Specification Comparison
C8H17N2O4SNa MDL Number MFCD00036463 Useful pH range 6.8 - 8.2 Molecular Weight 260.29 EG/EC Number 278-169-7 pKa (at 25) 7.5 CAS Number 75277-39-3 Sigma-Aldrich HEPES Sodium Salt Specifications Comparison
Data Sheet - D4943
et al., Biochim. Biophys. Acta, 657(1), 179-189 (1981). 3 7. Kenny, A.J., et al., Biochem. J., 157(1), 169-182 (1976). 8. Hegan, M., et al., Adv. Exp. Med. Biol.
Quality Control Range Sheet- A6602-106 and A6602-206
Control 2 98 – 203 pg/mL IL-15 Control 1 99 – 205 pg/mL MIG/CXCL9 Control 1 134 – 278 pg/mL Control 2 509 – 1058
XP725 Antibody Number-Lot Number 071M4826
226 227 228 249 250 251 252 273 274 275 276 3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
85 45 207 5751 std 6 180 97 200 138 278 392 75 286 154 276 184 306 64 352 8683 193 92 206 147 283 407 80 300 155 291 211 316 73 374 8251
Celltransmissions Newsletter
1825 (2000). 7. Huai, Q., et al., J. Biol. Chem., in press (2004). 8. Sung, B.J., et al., Nature, 425, 98-102 (2003). 9. Patel, S.B., et al., Acta Crystallogr. D. Biol. Crystallogr., 60, 169-171 (2004).
Protein Tyrosine Phosphatases- Potential Roles in Disease
76. Fujikawa, A., et al., Nat. Genet., 33, 375-381 (2003). 77. Yahiro, K., et al., J. Biol. Chem., 278, 19183-19189 (2003). 78. Liu, K., et al., J. Virol., 69, 7823-7834 (1995). 79. Guan, K., et al., Nature
The Ubiquitin-Proteasome System- Death of Proteins is Required for Life of Cells
(2001). 5. Weissman, A.M., Nature Rev. Cell Mol. Biol., 2, 169-179 (2001). 6. Joazeiro, C.A.P. and Weissman, A.M., Cell, 102, 549-552 (2000). 7. Deshaies, R.J., Annu. Rev. Cell Dev. Biol., 15, 435-467 (
Biologics 31.1
O’Rourke, B. 2004. Expert Opin. Investig. Drugs 13, 653; Uetani, T., et al. 2003. J. Biol. Chem. 278, 47491; Iwamoto, T., et al. 2001. Mol. Phar- macol. 59, 524; Pintado, A.J., et al. 2000. Br. J. Pharmacol
User Guide- 1.73027 - EN
storage in ambient relative humidity conditions of 20% to 95% Non-condensing Dimensions 418 × 278 × 169 mm (width × depth × height) Weight approx. 6.8 kg Warranty 24 months EMC Directive 2014
User Guide - 1.73026 - EN
storage in ambient relative humidity conditions of 20% to 95% Non-condensing Dimensions 418 × 278 × 169 mm (width × depth × height) Weight approx. 6.8 kg Warranty 24 months EMC Directive 2014
User Guide- 1.73028 - EN
storage in ambient relative humidity conditions of 20% to 95% Non-condensing Dimensions 418 × 278 × 169 mm (width × depth × height) Weight approx. 6.8 kg Warranty 24 months EMC Directive 2014
Inhibitor Sourcebook 3rd Edition
Tokyo) 129, 193. Rokolya, A., and Singer, H.A. 2000. Am. J. Physiol. 278, C537. Fukunaga, K., and Miyamoto, E. 1999. Jap. J. Pharmacol. 79, 7. Kemp, B.E., et al. 1994. In Protein Kinases (Woodgett, J.R., ed
XP725 Antibody List Lot 129K4831
d n/d 67 Bcl-x B9304 598 BCL2L1 P NP_001182.1 y y y 68 Bcl-xL B9429 598 BCL2L1 M NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1
XP725 Antibody List Lot 129K4830
d n/d 67 Bcl-x B9304 598 BCL2L1 P NP_001182.1 y y y 68 Bcl-xL B9429 598 BCL2L1 M NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1
XP725 Antibody List Lot 089K4791
d n/d 67 Bcl-x B9304 598 BCL2L1 P NP_001182.1 y y y 68 Bcl-xL B9429 598 BCL2L1 M NP_001182.1 y y y 278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d 69 BID B4305 637 BID P NP_001187.1
Bioreactor Systems for Bone Tissue Engineering
Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic 278 RAUH ET AL. expression and matrix mineralization. Proc Natl Acad Sci USA 101, 11203, 2004
XP725 Worksheet for Lot Number 071M4826
2 2 4 7 aCatenin C2081 272 2 2 4 8 aCatenin C2081 273 2 2 5 1 bCatenin C7207 274 2 2 5 2 bCatenin C7207 275 2 2 5 3 bCatenin C7082 276 2 2 5 4 bCatenin C7082 277 2 2 5 5
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
Ras-GST, agarose conj. ABA 100 µg 14-139 Ras Assay Reagent (Raf-1 RBD, agarose) ABA 600 µg 14-278 Ras, recombinant human full length Pur 100 µg SGT213 cDNA H-Ras cDNA (wt) in pUSEamp TFX 5
List of Antibodies
275 Fibronectin F3648 P y n/d n/d 276 Fibronectin F7387 M y y n/d 277 Filamin F1888 M n/d n/d n/d 278 Filensin F1043 M y y n/d 279 FKHR (FOXO1a) F6928 M y n/d n/d 280 FKHRL1 (FOXO3a) F2178 P y y
Cytoskeletal Signaling Antibodies, Reagents and Kits
Anti-RanGEF 17-218 Ras Activation Assay Kit 17-424 Ras Activation Plate Assay Kit 14-278 Ras Assay Reagent (Raf-1 RBD, Agarose) 14-139 GST-Ras agarose conjugate 14-863 Raf-1 Assay
Page 1 of 2